Medical Biochemistry & Metabolism
Complete rate-limiting enzyme catalogs, inborn errors of metabolism decoder (GSDs, LSDs, amino acid defects), electron transport chain inhibitors, and clinical vitamin matrices.
Genetic Code Characteristics, PDH Cofactors & Galactosemia
- • Unambiguous: Each codon specifies only ONE amino acid.
- • Degenerate / Redundant: Most amino acids are coded by multiple codons (wobble hypothesis at 3rd base position; exceptions: Methionine AUG, Tryptophan UGG).
- • Nonoverlapping & Commaless: Read continuously from fixed start codon AUG in triplets without punctuation.
- • Universal: Conserved across all species (slight exception in mitochondrial DNA).
The 5 cofactors of the Pyruvate Dehydrogenase (PDH) and α-Ketoglutarate Dehydrogenase complexes:
Mild, benign condition. Galactitol accumulates in lens → infantile cataracts (failure to track objects/social smile), galactose in urine. No hepatic or renal dysfunction.
Severe autosomal recessive deficiency of Galactose-1-Phosphate Uridyltransferase → toxic accumulation of Galactose-1-phosphate → cataracts, vomiting, jaundice, hepatomegaly, failure to thrive, intellectual disability, and life-threatening Escherichia coli sepsis in neonates.
In chronically starved patients (anorexia nervosa, severe alcoholism), carbohydrate refeeding triggers massive insulin surge → drives rapid cellular uptake of phosphate, potassium, and magnesium → profound hypophosphatemia → depleted ATP → arrhythmias, respiratory muscle failure, rhabdomyolysis, seizures, and death.
Interactive Metabolic Pathway Systems
Vector diagrams illustrating rate-limiting enzymes, allosteric control, electron flow, and clinical poison sites.
Glycolysis vs. Gluconeogenesis Switchpoints
Master control points at PFK-1 / FBPase-1 and Pyruvate Kinase / PEPCK with reciprocal allosteric regulation by Fructose-2,6-bisphosphate.
Tricarboxylic Acid (Krebs) Cycle & Anaplerosis
The 8-step hub generating 3 NADH, 1 FADH2, and 1 GTP per turn, with TLCFN cofactor requirements for PDH and α-KGDH complexes.
Electron Transport Chain Complexes & Inhibitors
Chemiosmotic proton pumping across Complexes I–IV driving ATP synthesis at Complex V, with exact binding sites of pharmacologic toxins and uncouplers.
Pentose Phosphate Pathway (HMP Shunt) & G6PD
Oxidative irreversible branch generating NADPH for glutathione reduction and fatty acid synthesis; non-oxidative branch synthesizing Ribose-5-P via Transketolase.
Fuel Homeostasis: Fed, Fasting & Starvation Switchboard
Chronological organ adaptation across postprandial (0-4h), fasting (4-24h), early starvation (1-3d), and prolonged starvation states, with hepatic ketogenesis regulation.
Master Rate-Limiting Enzymes & Allosteric Regulators
The exact biochemical switchpoints targeted on COMLEX Level 1 and USMLE Step 1.
| Pathway | Rate-Limiting Enzyme | Allosteric Activators (+) | Allosteric Inhibitors (-) | Cellular Compartment & Notes |
|---|---|---|---|---|
| Glycolysis | Phosphofructokinase-1 (PFK-1) | AMP, Fructose-2,6-bisphosphate (F-2,6-BP) | ATP, Citrate | Cytosol. Insulin activates PFK-2 → ↑F-2,6-BP → stimulates glycolysis. Glucagon stimulates FBPase-2. |
| Gluconeogenesis | Fructose-1,6-bisphosphatase-1 | Citrate, ATP | AMP, F-2,6-BP | Cytosol (Liver/Kidney). 4 unique bypass enzymes: Pyruvate carboxylase (biotin), PEP carboxykinase, F-1,6-BPase, Glucose-6-phosphatase. |
| TCA (Krebs) Cycle | Isocitrate Dehydrogenase | ADP, NAD+ | ATP, NADH | Mitochondrial matrix. Produces 3 NADH, 1 FADH2, 1 GTP per acetyl-CoA (10 ATP total per acetyl-CoA). |
| Glycogenesis | Glycogen Synthase | Glucose-6-phosphate, Insulin, Cortisol | Epinephrine, Glucagon (via PKA phosphorylation) | Cytosol. Forms α-1,4 bonds. Branching enzyme forms α-1,6 linkages. |
| Glycogenolysis | Glycogen Phosphorylase | Epinephrine, Glucagon, AMP, Ca2+ (calmodulin in muscle) | Glucose-6-phosphate, ATP, Insulin | Cytosol. Cleaves α-1,4 bonds yielding glucose-1-phosphate. Deficient in McArdle (muscle) and Hers (liver). |
| HMP Shunt (Pentose Phosphate) | Glucose-6-Phosphate Dehydrogenase (G6PD) | NADP+ | NADPH | Cytosol. Yields NADPH (for glutathione reduction, fatty acid/sterol synthesis) & Ribose-5-P (for nucleotides). G6PD deficiency → Heinz bodies & bite cells under oxidative stress. |
| Fatty Acid Synthesis | Acetyl-CoA Carboxylase (ACC) | Insulin, Citrate | Glucagon, Palmitoyl-CoA | Cytosol. Requires biotin (B7), ATP, and CO2. Product malonyl-CoA inhibits carnitine palmitoyltransferase-1 (CPT-1) to halt beta-oxidation. |
| Fatty Acid Beta-Oxidation | Carnitine Acyltransferase I (CPT-1) | Glucagon, low malonyl-CoA | Malonyl-CoA (synthesis intermediate) | Mitochondrial outer membrane → matrix. Carnitine shuttle transports long-chain fatty acids into matrix. Systemic carnitine deficiency → hypoketotic hypoglycemia. |
| Ketogenesis | HMG-CoA Synthase | Fasting, low oxaloacetate, high acetyl-CoA | Insulin | Liver mitochondria only (RBCs cannot use ketones, lack mitochondria; liver cannot use ketones, lacks thiophorase/SCOT). |
| Cholesterol Synthesis | HMG-CoA Reductase | Insulin, Thyroxine | Statins (competitive), Glucagon, Cholesterol | Smooth ER. Converts HMG-CoA to mevalonate. Statins competitively inhibit; side effects = myopathy & hepatotoxicity. |
| Urea Cycle | Carbamoyl Phosphate Synthetase I (CPS I) | N-acetylglutamate (NAG) | Low arginine | Mitochondria (CPS I & OTC); Cytosol (Argininosuccinate synthetase/lyase, Arginase). NAG is an obligate allosteric activator. |
Electron Transport Chain Complexes & Classic Poisons
High-yield mechanism correlations tested on toxicological and cellular respiration questions.
Directly halts electron transfer from NADH to CoQ (Ubiquinone), eliminating the proton gradient from Complex I.
Blocks electron transfer from Cytochrome b to Cytochrome c1, freezing upstream cytochromes in reduced state.
Inhibits Cytochrome c oxidase (Fe3+ in Cyanide, Fe2+ in CO). Halts cellular aerobic respiration; severe lactic acidosis with high venous oxygen saturation in cyanide.
Oligomycin directly blocks F0 proton pore (halts ATP & electron flow). 2,4-DNP & Aspirin dissipate proton gradient as heat → hyperthermia, tachypnea, ↑O2 consumption.
Electron Transport Chain & Oxidative Phosphorylation
Mitochondrial proton electrochemical gradient, Complexes I–V, specific chemical inhibitors, and fatal uncoupling agents.
Complexes & Electron Shuttles
- Complex I (NADH Dehydrogenase): Transfers electrons from NADH to Coenzyme Q (Ubiquinone). Pumps 4 H+ into intermembrane space.
- Complex II (Succinate Dehydrogenase): Only enzyme shared by TCA cycle and ETC! Transfers electrons from FADH2 to Coenzyme Q. Pumps NO protons.
- Complex III (Cytochrome bc1): Transfers electrons from Coenzyme Q to Cytochrome c. Pumps 4 H+.
- Complex IV (Cytochrome c Oxidase): Contains copper (Cu) and heme irons (a/a3). Transfers electrons to molecular O2 to form H2O. Pumps 2 H+.
- Complex V (ATP Synthase / F0F1): Uses proton-motive force to spin F1 subunit and synthesize ATP from ADP + Pi.
ETC Inhibitors vs. Uncoupling Agents
Halts electron flow → proton gradient collapses → ↓ O2 consumption, ↓ ATP synthesis, lactic acidosis.
Complex I: Rotenone, Amytal, Metformin • Complex III: Antimycin A • Complex IV: Cyanide, CO, Sodium Azide, H2S • Complex V: Oligomycin
Increases inner membrane H+ permeability → dissipates proton gradient without passing through ATP synthase → ↑ O2 consumption, ↓ ATP synthesis, energy released as massive heat.
Agents: 2,4-Dinitrophenol (DNP - illegal fat burner), High-dose Aspirin (hyperthermia, tachypnea), Thermogenin (UCP-1 in brown fat of newborns).
Fructose, Galactose & The Sorbitol Osmotic Pathway
Comparative enzyme deficiencies, cellular trapping mechanics, and polyol diabetic microvascular complications.
Fructose Disorders
Fructokinase (Benign) vs. Aldolase B (Fatal Phosphate Trapping)Autosomal recessive, completely benign & asymptomatic. Fructose cannot be phosphorylated to F-1-P; it simply accumulates in the blood and is excreted freely in urine.
Autosomal recessive, life-threatening. Fructose-1-Phosphate accumulates → traps intracellular inorganic phosphate (Pi) → severe ATP depletion → inhibits glycogenolysis and gluconeogenesis.
Classic Vignette: Healthy infant recently introduced to fruit, fruit juices, honey, or table sugar (weaning). Presents with profound fasting hypoglycemia, vomiting, jaundice, hepatomegaly, cirrhosis, and renal Fanconi dysfunction.
Galactose Disorders
Galactokinase (GALK) vs. Classic Galactosemia (GALT)Autosomal recessive. Galactose accumulates and is shunted into Galactitol via Aldose Reductase. Galactitol exerts osmotic pressure in the ocular lens.
Autosomal recessive. Deficiency of Galactose-1-Phosphate Uridyltransferase → toxic accumulation of Galactose-1-P and Galactitol across the lens, liver, and brain.
Classic Vignette: Develops within days of initiating breast milk or cow-milk formula: failure to thrive, jaundice, hepatosplenomegaly, bilateral oil-droplet cataracts, intellectual disability, and life-threatening Escherichia coli neonatal sepsis.
The Sorbitol Polyol Pathway & Diabetic Complications
Aldose Reductase vs. Sorbitol Dehydrogenase tissue disparity in chronic hyperglycemiaTissues equipped with both enzymes (Liver, Ovaries, Seminal vesicles) readily metabolize sorbitol to fructose without damage. In semen, fructose provides essential motility fuel for spermatozoa.
In uncontrolled diabetes mellitus, chronic hyperglycemia saturates Hexokinase/Glucokinase. Excess intracellular glucose floods Aldose Reductase, generating massive quantities of intracellular Sorbitol. Because target tissues lack or have negligible Sorbitol Dehydrogenase, polar sorbitol cannot cross membranes and is trapped, pulling in water osmotically and causing cell edema, oxidative stress (via NADPH depletion), and cellular lysis.
Intracellular sorbitol accumulation pulls water osmotically into the lens matrix → hydropic fiber degeneration and opacity formation → classic diabetic cataracts (snowflake cataracts).
Selective osmotic loss of retinal pericytes → capillary wall outpouching → microaneurysms, dot-and-blot hemorrhages, and cotton-wool spots → diabetic retinopathy.
Sorbitol hyperosmolarity combined with advanced glycation end-products (AGEs) → mesangial expansion, GBM thickening → Kimmelstiel-Wilson nodular glomerulosclerosis.
Osmotic swelling damages Schwann cell architecture → segmental demyelination and axonal degeneration → symmetric distal stocking-glove polyneuropathy and autonomic dysfunction.
Fed vs. Fasting States: 4-Phase Metabolic Timeline
Organ fuel priorities, hormone-driven enzyme switches, and protein-sparing adaptation in extended starvation.
| Metabolic Phase | Timeframe | Endocrine Profile | Primary Blood Glucose Source | Peripheral Tissue Fuel | Brain Fuel |
|---|---|---|---|---|---|
| 1. Absorptive (Well-Fed) | 0 – 4 hours post-meal | High Insulin / Low Glucagon | Exogenous dietary carbohydrates | Glucose (GLUT-4 in muscle & adipose); liver stores glycogen & synthesizes TAGs | 100% Glucose |
| 2. Postabsorptive (Early Fast) | 4 – 18 hours | Falling Insulin / Rising Glucagon & Epinephrine | Hepatic Glycogenolysis (primary); early onset of gluconeogenesis | Adipose lipolysis via HSL releases FFAs; muscle switches to Free Fatty Acids (FFAs) | 100% Glucose |
| 3. Early Starvation | 18 hours – 3 days | Very Low Insulin / High Glucagon, Cortisol, Epinephrine | Hepatic Gluconeogenesis (glycogen stores fully exhausted by ~24h). Substrates: muscle amino acids (alanine), lactate, and adipose glycerol. | Free Fatty Acids (FFAs) & early Ketone Bodies. Liver floods with FFAs → excess Acetyl-CoA → Ketogenesis begins. | Glucose (primary) + emerging Ketone Bodies |
| 4. Extended Starvation | > 3 days – weeks | Basal Insulin / Sustained Glucagon & Epinephrine | Renal & Hepatic Gluconeogenesis (minimal glucose required, protein-sparing state) | Adipose FFAs; vital muscle protein degradation is dramatically suppressed to maintain diaphragm and myocardium | β-Hydroxybutyrate & Acetoacetate (~70% of total energy); ~30% Glucose |
Ethanol Metabolism & The High NADH/NAD+ Ratio Cascade
Zero-order kinetics, targeted pharmacology, and the four fatal metabolic shifts of alcoholic hypoglycemia and ketoacidosis.
Cytosolic Step: Alcohol Dehydrogenase (ADH)
Zero-Order Elimination Kinetics • High-Yield Antidote TargetOperates by zero-order elimination kinetics at clinical alcohol levels because ADH is saturated at very low ethanol concentrations (~10 mg/dL). A constant amount (~7–10 g/hour or ~1 drink/hour) is cleared regardless of serum level.
First-line antidote for Methanol (windshield wiper fluid → optic neuritis/blindness via formic acid) and Ethylene Glycol (automotive antifreeze → acute tubular necrosis / calcium oxalate monohydrate envelope crystals via glycolic/oxalic acid). Fomepizole blocks ADH, halting the production of toxic organic acids.
Mitochondrial Step: Acetaldehyde Dehydrogenase (ALDH)
Aversive Reaction Mechanics • Disulfiram-Like MedicationsAcetaldehyde is toxic and vasoreactive. Its accumulation causes facial flushing, nausea, throbbing headache, diaphoresis, and reflex tachycardia. Polymorphic inactive ALDH2 (*2 allele) is highly prevalent in East Asian populations.
Prescribed for alcohol abstinence by inducing violent physical aversion upon alcohol ingestion. High-Yield Board Rule: Medications triggering disulfiram-like reactions with alcohol include Metronidazole, Cefoperazone / Cefotetan, Griseofulvin, and 1st-generation sulfonylureas.
The 4 Classic Derangements of Elevated NADH/NAD+ Ratio
Both ADH and ALDH generate NADH, depleting cellular NAD+ and violently reversing dehydrogenase equilibriaMassive cytosolic NADH drives the malate dehydrogenase equilibrium strongly toward malate, effectively depleting intracellular oxaloacetate (OAA). Because OAA is the obligate substrate for PEPCK, hepatic gluconeogenesis is completely paralyzed.
Chronic malnourished alcoholic found unresponsive on Sunday morning with blood glucose 24 mg/dL. Hepatic glycogen stores were depleted from malnutrition, and gluconeogenesis was shut down by alcohol metabolism.
Surplus NADH forces lactate dehydrogenase (LDH) to convert pyruvate into lactate. This not only strips the cell of pyruvate (compounding gluconeogenesis failure) but causes severe systemic lactic acidosis with elevated anion gap.
ABG demonstrates pH 7.20, HCO3 11 mEq/L, and anion gap of 24 with serum lactate 7.2 mmol/L in the absence of sepsis, shock, or tissue hypoperfusion.
Elevated NADH shifts dihydroxyacetone phosphate (DHAP) toward glycerol-3-phosphate. Glycerol-3-P acts as the carbon backbone for esterifying circulating fatty acids into triglycerides, creating rapid macrovesicular steatosis.
Painless hepatomegaly with hyperechoic liver on ultrasound, AST:ALT ratio > 2:1 (mitochondrial AST leakage), and elevated serum triglycerides. Reversible with alcohol cessation.
High NADH inhibits isocitrate DH and α-KGDH, stalling the TCA cycle. Surplus acetyl-CoA is shunted into ketogenesis. High NADH shifts acetoacetate almost entirely into β-hydroxybutyrate.
Standard urine dipstick (nitroprusside) is falsely negative or only trace positive because nitroprusside reacts ONLY with acetoacetate, NOT β-hydroxybutyrate!
Master Fed vs. Fasting Hormonal Signal & Enzyme Phosphorylation Matrix
The definitive board rule: Insulin promotes DEPHOSPHORYLATION; Glucagon & Epinephrine promote PHOSPHORYLATION.
Signaling Pathway: Insulin binds Receptor Tyrosine Kinase (RTK) → autophosphorylation → IRS-1/2 recruitment → PI3K/Akt pathway activation → stimulates Protein Phosphatase 1 (PP1).
Enzyme Effect: PP1 strips phosphate groups off key enzymes → Enzymes become DEPHOSPHORYLATED.
Net Metabolic Flux: Glycogen synthesis ON, Glycolysis ON, Fatty acid synthesis ON, Protein translation ON. Breakdown pathways shut OFF.
Signaling Pathway: Glucagon (liver) & Epinephrine (β receptors) bind Gs GPCR → stimulates Adenylyl Cyclase → ↑ cAMP → activates Protein Kinase A (PKA).
Enzyme Effect: PKA transfers ATP phosphates onto serine/threonine residues → Enzymes become PHOSPHORYLATED.
Net Metabolic Flux: Glycogenolysis ON, Gluconeogenesis ON, Lipolysis (adipose) ON, Ketogenesis (liver) ON. Storage pathways shut OFF.
| Key Metabolic Pacemaker | Pathway | Dephosphorylated (Insulin / PP1) | Phosphorylated (Glucagon / PKA) | Crucial Board Takeaway & Allosteric Modulators |
|---|---|---|---|---|
| Glycogen Synthase | Glycogenesis | ACTIVE (Stores glycogen) | INACTIVE | Allosterically activated by Glucose-6-Phosphate in liver & muscle. |
| Glycogen Phosphorylase | Glycogenolysis | INACTIVE (Phosphorylase b) | ACTIVE (Phosphorylase a) | Activated by Phosphorylase Kinase (activated by PKA and Ca2+-calmodulin during muscle contraction). Allosteric activator in muscle: AMP. Inhibitors: ATP, G6P. |
| Bifunctional Enzyme: PFK-2 / FBPase-2 |
Glycolytic Switch |
PFK-2 is ACTIVE ↑ Fructose-2,6-bisphosphate → Powerful allosteric activation of PFK-1 (Glycolysis ON) |
FBPase-2 is ACTIVE ↓ Fructose-2,6-bisphosphate → Relieves inhibition of FBPase-1 (Gluconeogenesis ON) |
High-Yield Mnemonic: "fabulous Fed Peasants" (Fed = PFK-2 active). In fasting, PKA phosphorylates both domains → inactivates kinase, activates phosphatase. |
| Pyruvate Dehydrogenase (PDH) | Pyruvate → Acetyl-CoA | ACTIVE (PDH Phosphatase stimulated by Ca2+, Mg2+, insulin) | INACTIVE (PDH Kinase stimulated by ATP, NADH, Acetyl-CoA) | High mitochondrial energy charge (ATP, NADH, Acetyl-CoA) shuts off PDH via kinase activation → shunts pyruvate to oxaloacetate via Pyruvate Carboxylase (gluconeogenesis). |
| Acetyl-CoA Carboxylase (ACC) | Fatty Acid Synthesis | ACTIVE (Polymerized form; produces Malonyl-CoA) | INACTIVE (Phosphorylated by AMPK and PKA) | Rate-limiting enzyme of lipogenesis. Requires Biotin (B7). Its product, Malonyl-CoA, allosterically inhibits Carnitine Palmitoyltransferase-I (CPT-I), preventing simultaneous β-oxidation! |
| Hormone-Sensitive Lipase (HSL) | Adipocyte Lipolysis | INACTIVE (Lipolysis halted) | ACTIVE (Hydrolyzes stored triacylglycerols → FFAs + glycerol) | Insulin strongly suppresses HSL via PP1, preventing ketoacidosis. In untreated Type 1 DM (zero insulin), uninhibited HSL floods liver with free fatty acids → massive ketogenesis and DKA. |